B7-33 Protocol: Beginner to Advanced

Typical dose

500 mcg

Frequency

Once daily or every other day, subcutaneous (community practice only). B7-33 has a very short half-life; no validated human dosing schedule exists.

Cycle length

Typically 4-12 weeks on with 4-8 week off-periods between cycles (community convention; not clinically validated).

Route

How long is a typical B7-33 protocol?

Standard B7-33 protocols run 4 weeks for a full Intermediate cycle. Beginner cycles compress to ~2 weeks for response assessment. Advanced cycles extend to ~5 weeks but require closer monitoring.

What's the safest dose to start a B7-33 cycle with?

The Beginner tier starts at 250 mcg once daily or every other day, subcutaneous (community practice only). b7-33 has a very short half-life; no validated human dosing schedule exists., half the published Intermediate-tier dose. Hold for 2-3 weeks to assess tolerance and response, then escalate to the standard 500 mcg if no adverse signals.

Do I need to cycle off B7-33?

Cycling depends on the compound's mechanism. Receptor-saturating compounds (most peptides) benefit from 4-6 week off-cycles between protocols to prevent downregulation. Non-saturating compounds (some healing peptides) can run continuously. The full B7-33 research profile covers this in detail; see the cross-links below.

Can I stack B7-33 with other compounds?

Stacking is common for synergistic effects, but each compound's mechanism, half-life, and route of administration matter. Use the BodyHackGuide stack builder + interaction checker to validate any pairing. The "Where to source" section below ranks vendors who carry B7-33 alongside complementary compounds in one shipment.